ZICCUM AB Interim Report Q.3 2018
Stockholm, Sweden, November 15 2018, Summary of interim report - Third Quarter and first nine months 2018: During the first nine months, Ziccum AB generated capital through borrowing 2.25 MSEK, achieved proof of concept by drying selected antibodies, and received its first order regarding a feasibility project for a customer with a substance in preclinical development. On October 3, 2018 the subscription period for Ziccum's new issue of units ahead of the planned listing on Spotlight was completed. The new share issue of 15.8 MSEK was subscribed to approx. SEK 52.7 million, a subscription